| Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978) |
|---|
| 05/03/2001 | CA2387857A1 Tissue factor antagonists and methods of use thereof |
| 05/02/2001 | EP1095937A1 Process for the preparation of trisubstituted oxazoles |
| 05/02/2001 | EP1095040A1 New benzoxazoles with pde-inhibiting activity |
| 05/02/2001 | EP1094826A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors |
| 05/02/2001 | EP0984959A4 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
| 05/02/2001 | EP0983257A4 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds |
| 05/02/2001 | EP0973392A4 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 05/01/2001 | US6225625 Signal detection methods and apparatus |
| 05/01/2001 | US6225331 For therapy and prophylaxis nasal congestion, otitis media, and sinusitis, treating cough, chronic obstructive pulmonary disease (copd) and/or asthma, benign prostatic hypertrophy, cardiovascular disorders, glaucoma, hyperemia, conjunctivitis |
| 05/01/2001 | US6225326 Administering insulin sensitivity enhancer in combination with an .alpha.-glucosidase inhibitor for therapy to reduce side effect for diabetic patient |
| 05/01/2001 | US6225312 Piperazine and piperidine compounds |
| 05/01/2001 | US6224849 Alkylaminobenzothiazole and-benzoxazole derivatives |
| 04/27/2001 | CA2324433A1 Process for the preparation of trisubstituted oxazoles |
| 04/26/2001 | WO2001029013A1 Process for preparing oxazolines from tetrahydrofurans |
| 04/26/2001 | WO2001028987A1 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 04/26/2001 | WO2001028979A2 Inhibitors of neuraminidases |
| 04/26/2001 | WO2000055139A3 Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 04/26/2001 | CA2384240A1 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 04/25/2001 | CN1292791A Herbicidally active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives |
| 04/24/2001 | US6222044 Reacting an aromatic aldehyde with hydroxylamine to form an aromatic aldehyde oxime, halogenating oxime to form aromatic hydroxamoyl halide, and reacting with aromatic amine compounds to form benzoxazole, benzothiaxole, benzimidazoles |
| 04/24/2001 | US6222043 Coupling 2-amido-thiazole derivative with 2-phenyl4-(protected)amino-butyric acid; deprotecting amino protecting group; acylating product with carboxylic acid containing carbocyclic or heterocyclic group; deprotecting |
| 04/24/2001 | US6221902 Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia |
| 04/24/2001 | US6221865 Inhibitors of protein farnesyltransferase and protein geranylgeranyltransferase. |
| 04/19/2001 | WO2001027088A1 Lpl potentiators |
| 04/19/2001 | WO2001027084A1 Beta disubstituted metalloprotease inhibitors |
| 04/19/2001 | WO2001026656A2 5-membered heterocycle derivatives and use thereof as monoamine oxidase inhibitors |
| 04/19/2001 | WO2000018767A9 2-piperazino alkylamino benzoazole derivatives: dopamine receptor subtype specific ligands |
| 04/19/2001 | US20010000345 Compounds such as (4,7-dimethylbenzimidazol-5-yl)guanidine; treating nasal congestion, otitis media, asthma, pain, migraine, gastrointestinal disorder, ulcer |
| 04/19/2001 | CA2388505A1 5-membered heterocycle derivatives, their preparation and application as medicine |
| 04/19/2001 | CA2386485A1 Beta disubstituted metalloprotease inhibitors |
| 04/18/2001 | EP1092712A1 Process for preparing fungicidal oxazolidinones and imidazolinones |
| 04/18/2001 | EP1092711A1 Retinoid-associated receptor regulators |
| 04/18/2001 | EP1092706A1 Process for the preparation of phenylalkanoic acid amides and intermediates therefor |
| 04/18/2001 | EP1092705A1 Process for the preparation of amides |
| 04/18/2001 | EP1091943A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 04/18/2001 | EP0740661B1 Diphenyl oxazoline derivatives |
| 04/18/2001 | CN1291998A Method for cross-linking hydrogels with bis-and poly-2-oxazolidinones |
| 04/17/2001 | US6218550 Intermediates useful for the manufacture of carbapenem and a stereoselective manufacturing method therefor |
| 04/17/2001 | US6218544 Heterocyclic esters and amides |
| 04/17/2001 | US6218429 Tricyclic compounds, their production and use |
| 04/17/2001 | US6218413 Oxazolidinone antibacterial agents having a thiocarbonyl functionality |
| 04/17/2001 | US6218409 Administering insulin sensitivity enhancer in combination with an aldose reductase inhibitor for reducing side effects of diabetic drugs |
| 04/17/2001 | US6218359 Treating autoimmune, arthritic, tumor diseases |
| 04/17/2001 | CA2080475C Neuroprotective indolone and related derivatives |
| 04/12/2001 | WO2001025181A1 Carboxylic acid derivatives and drugs containing the same |
| 04/12/2001 | WO2001024828A2 MODULATORS OF CYTOKINE MEDIATED SIGNALLING PATHWAYS AND INTEGRIN αVβ3 RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
| 04/12/2001 | WO2001024827A2 INHIBITORS OF THE ENDOTHELIN SIGNALLING PATHWAY AND αVβ3 INTEGRIN RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
| 04/12/2001 | DE19948269A1 New compounds as integrin antagonists useful for treating e.g. cardiovascular disorders, rheumatoid arthritis, kidney failure, stroke, cancer, osteoporosis, psoriasis or infection |
| 04/12/2001 | CA2386457A1 Inhibitors of the endothelin signalling pathway and .alpha.v.beta.3 integrin receptor antagonists for combination therapy |
| 04/11/2001 | EP1090914A2 Processes and intermediates for manufacturing retroviral protease inhibiting compounds |
| 04/11/2001 | EP1089989A1 Inhibitors of alpha4beta1 mediated cell adhesion |
| 04/11/2001 | CN1291202A Secondary cross-linking of hydrogels with 2-oxazolidinones |
| 04/11/2001 | CN1291183A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors |
| 04/11/2001 | CN1064350C Aryl and heteroaryl alkoxynaphtalene derivatives |
| 04/10/2001 | US6214877 Antidiabetic agents; modulator of glucose concentration |
| 04/10/2001 | US6214852 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases |
| 04/10/2001 | US6214848 Insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action for prophylaxis and treatment of diabetes; depressing diabetic hyperglycemia |
| 04/10/2001 | US6214829 Piperazine compounds, their preparation, and methods of using them |
| 04/10/2001 | US6214820 Peroxisome proliferator activated receptors |
| 04/10/2001 | CA2162106C 5-(aryloxymethyl)oxazolines, process for preparing the same and pharmaceutical compositions containing them |
| 04/10/2001 | CA2133413C Indole derivatives as 5-ht1 antagonists |
| 04/05/2001 | WO2000057877A8 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof |
| 04/04/2001 | EP1087952A1 Benzazole compounds and their use |
| 04/04/2001 | EP1087941A2 Thiolesters and uses thereof |
| 04/04/2001 | EP1087938A1 Inhibitors of neuraminidases |
| 04/03/2001 | US6211214 Pesticides, insecticides or miticides |
| 04/03/2001 | US6211207 Pharmaceutical composition |
| 04/03/2001 | US6211206 Pharmaceutical composition |
| 04/03/2001 | US6211205 Pharmaceutical composition |
| 03/29/2001 | WO2001021604A1 Substituted piperazine derivatives, the production thereof and their use as inhibitors of the microsomal triglyceride-transfer protein (mtp) |
| 03/29/2001 | WO2001021602A1 Oxa- and thiazole derivatives useful as antidiabetic and antiobesity agents |
| 03/29/2001 | WO2001021601A1 Oxazolin-2 compound and method for preparing trimebutine |
| 03/29/2001 | WO2001021584A1 Tyrosine derivatives |
| 03/29/2001 | WO2001021583A1 Hydroxamic acid derivatives, process for the production thereof and drugs containing the same as the active ingredient |
| 03/29/2001 | WO2001021577A2 Melanin concentrating hormone antagonist |
| 03/29/2001 | DE19945594A1 Substituierte Piperazinderivate, ihre Herstellung und ihre Verwendung als Arzneimittel Substituted piperazine derivatives, their preparation and their use as medicaments |
| 03/29/2001 | CA2386474A1 Melanin concentrating hormone antagonist |
| 03/28/2001 | EP1086065A4 Combinatorial synthesis of multibinding libraries |
| 03/28/2001 | EP1086065A1 Combinatorial synthesis of multibinding libraries |
| 03/28/2001 | EP1085894A1 Beta 3-adrenergic receptor agonists |
| 03/28/2001 | EP1085893A1 Phosphodiesterase-v modulator drugs and their uses |
| 03/28/2001 | EP1085891A1 Multibinding inhibitors of topoisomerase |
| 03/28/2001 | EP1085889A2 Novel therapeutic agents that modulate endothelin receptors |
| 03/28/2001 | EP1085887A2 Novel angiotensin receptor modulators and their uses |
| 03/28/2001 | EP1085870A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 03/28/2001 | EP1085868A1 H1-histamine receptor antagonists |
| 03/28/2001 | EP1085861A1 Inhibitors of nitric oxide synthase |
| 03/28/2001 | EP1085847A2 Novel therapeutic agents that modulate estrogen receptors |
| 03/28/2001 | EP1085846A2 Multibinding inhibitors of microsomal triglyceride transferase protein |
| 03/28/2001 | EP0708762B1 Process for making hiv protease inhibitors |
| 03/28/2001 | CN1289248A Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| 03/27/2001 | US6207822 Reacting p-fluorobenzoylbutyric acid with pivaloyl chloride;acylation; reduction; cyclization; hydrosilation; deblocking |
| 03/27/2001 | US6207697 Amidinyl-substituted rings; anticoagulants; thromboembolic disorders; antiischemic and antiinflammatory agents; strokes; serine protease inhibitors |
| 03/27/2001 | US6207693 Benzamide derivatives having a vasopressin antagonistic activity |
| 03/27/2001 | US6207663 Vitronectin receptor antagonists, their preparation and use |
| 03/22/2001 | WO2001019806A1 Process for the preparation of oxazole derivatives |
| 03/22/2001 | WO2001019805A1 Heterocyclic compounds and process for the preparation thereof |
| 03/22/2001 | WO2001019780A2 Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 03/22/2001 | WO2001019778A1 Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 03/22/2001 | WO1999063936A8 Novel therapeutic agents that modulate endothelin receptors |